Senate Bill 2556, also known as House Bill 2136, mandates that the Tennessee Department of Health submit a comprehensive report by January 1, 2027, detailing each medication approved by the federal Food and Drug Administration (FDA) specifically for women's health. This report must include a synopsis of each medication and be delivered to both the Speaker of the Senate and the Speaker of the House of Representatives.

The bill emphasizes the importance of tracking and understanding medications that impact women's health, ensuring that state legislators are informed about these FDA-approved treatments. The act will take effect immediately upon becoming law, highlighting its urgency in addressing women's health issues.